← Return to Anyone chosen palliative care? What are the last months/weeks like?

Discussion

Anyone chosen palliative care? What are the last months/weeks like?

Pancreatic Cancer | Last Active: Sep 26 9:48pm | Replies (42)
Comment receiving replies
@stageivsurvivor

KRAS G12C targeted with Keytruda (Pembrolizumab) shows a high response rate. Only about 3% of KRAS mutated cancers are due to G12C. It is more common in Non Small Cell Lung Cancer.

Jump to this post

Replies to "KRAS G12C targeted with Keytruda (Pembrolizumab) shows a high response rate. Only about 3% of KRAS..."
marienewland | @mnewland99 | Aug 26 9:37am

Thank you, StageIV, I always look forward to your sage advice! Yes, I’m aware of Keytruda having success with KRAS12C. It’s a start at least for the KRAS mutations. I believe better things for other KRAS mutations are bound for the future. Can you respond to my question on another thread about how to determine a 0.9 cm lung nodule I have in my right lung lobe isn’t cancer as the medical (not pancreatic) oncologist is advising against a biopsy due to possibility of puncturing the lung. The PET scan noted it wasn’t appreciably metabolic. My CA19-9 is rising like crazy, but PET scan shows I may have a cancerous lesion in my femur.

VIEW AND REPLY